08.02.12
West
2Q Revenues: $324.8 million (+6%)
2Q Earnings: $15.6 million (-22%)
YTD Revenues: $641.1 million (+6%)
YTD Earnings: $44.8 million (+13%)
Comments: Pharmaceutical Packaging Systems segment sales grew 6% due to improved sales and increased selling prices. Pharmaceutical Delivery Systems sales grew 3% from increases in safety syringe system sales and contract services. R&D increased by $0.9 million, primarily for further investment in the development of the SmartDose electronic patch injection system. Restructuring, impairment and related charges were $3.7 million in the quarter. Charges of $1.3 million in the quarter and $3.2 million YTD were associated with the December 2010 restructuring and employee severance and benefits, as well as asset transfer and facility closure costs.
2Q Revenues: $324.8 million (+6%)
2Q Earnings: $15.6 million (-22%)
YTD Revenues: $641.1 million (+6%)
YTD Earnings: $44.8 million (+13%)
Comments: Pharmaceutical Packaging Systems segment sales grew 6% due to improved sales and increased selling prices. Pharmaceutical Delivery Systems sales grew 3% from increases in safety syringe system sales and contract services. R&D increased by $0.9 million, primarily for further investment in the development of the SmartDose electronic patch injection system. Restructuring, impairment and related charges were $3.7 million in the quarter. Charges of $1.3 million in the quarter and $3.2 million YTD were associated with the December 2010 restructuring and employee severance and benefits, as well as asset transfer and facility closure costs.
